Mr. Wang Jin, a senior angel investor, graduated from Zhejiang University (formerly Hangzhou University) and Worcester Institute of Technology (with a PhD in biomedicine). He is currently one of the founding partners of Manhattan Capital and has been engaged in equity investment and performance transformation in Chinese-American technology innovation companies for 25 years. He has rich practical experience and successful cases. He has invested in and built dozens of technology companies, including Polarx Pharmaceuticals, Dingxiangyuan, Koteng Biotechnology and Zhiwei Technology. Before returning to China as an entrepreneur, he worked in research and development at Roche Pharmaceuticals and worked at Paramount Capital as a regional director for Asia Pacific and China director of a cell therapy company. He is currently a director and consultant for several companies, has coached many startups, and has served as a director and donor for several non-profit funds and charitable organizations.